scispace - formally typeset
M

Margareth Pretti Dalcolmo

Researcher at Oswaldo Cruz Foundation

Publications -  81
Citations -  2836

Margareth Pretti Dalcolmo is an academic researcher from Oswaldo Cruz Foundation. The author has contributed to research in topics: Tuberculosis & Medicine. The author has an hindex of 23, co-authored 66 publications receiving 2116 citations. Previous affiliations of Margareth Pretti Dalcolmo include Federal University of São Paulo & Pontifical Catholic University of Rio de Janeiro.

Papers
More filters
Journal ArticleDOI

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

Nafees Ahmad, +107 more
- 08 Sep 2018 - 
TL;DR: Treatment outcomes were significantly better with use of linezolid, later generation fluoroquinolones, bedaquiline, clofazimine, and carbapenems for treatment of multidrug-resistant tuberculosis, and the need for trials to ascertain the optimal combination and duration of these drugs is emphasised.
Journal ArticleDOI

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Sergey Borisov, +64 more
TL;DR: Bedaquiline-containing regimens achieved high conversion and success rates under different nonexperimental conditions, and is safe and effective in treating MDR- and XDR-TB patients.
Journal ArticleDOI

II Consenso Brasileiro de Tuberculose: Diretrizes Brasileiras para Tuberculose 2004

TL;DR: “.” ˛˚ ˛ ˜ˇ 2 ˆ````龍左 𝚘 , 7˚, 7˘ ݘ ンジャック, ݚ വ’ “’Benedictine’s Law”, 2 January 2017.